Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

Share Price is delayed by 15 minutes
Get Live Data
2,619.00    -20.00 (-0.76%)
Bid:
2,621.00
Ask:
2,625.00
Spread: 4.00 (0.153%)
Market Cap: £23.39b
EXPN Live PriceLast checked at - London Stock Exchange

Intraday Experian Share Chart

Directorate Changes

19 Jan 2022 07:00

RNS Number : 8753Y
Experian plc
19 January 2022
 

Directorate Changes

 

19 January 2022  Experian, the global information services company, today announces that after 19 years at Experian, Kerry Williams has notified the Company of his intention to retire as Chief Operating Officer and as an Executive Director of the Company. To ensure a smooth succession process, Kerry will remain with Experian through to 31 March 2023.

 

Craig Boundy will succeed Kerry Williams. Craig has successfully led Experian's North America region for seven years, having joined Experian in November 2011 to lead the UK & Ireland region, and operated in a variety of leading management positions. Craig will assume the position of Chief Operating Officer on 1 April 2022 and will join the Board as an Executive Director of the Company from the conclusion of the Company's AGM in July 2022, when Kerry will step down from the Board.

 

Jennifer Schulz will assume the role of CEO, North America for Experian from 1 April 2022. Jennifer joined Experian in 2013 and is currently Group President of our North America Health and Automotive businesses and global Targeting and Data Quality (EDQ) businesses.

 

Mike Rogers, Experian's Chairman said "Experian has made tremendous progress over the past few years and we are immensely grateful to Kerry for his outstanding contribution to this success. Craig's commercial and operational expertise, as well as his commitment to fostering diversity, equity and inclusion within Experian, will bring equally deep knowledge and perspectives to the Experian plc Board."

 

Brian Cassin, Experian's Chief Executive Officer said "Kerry, Craig and Jennifer are extraordinary leaders and we are fortunate to have access to talent of this calibre so widely across Experian. Kerry has played a pivotal role in taking the business to the strong position it is in today. We thank him for this and wish him well for his retirement. Craig and Jennifer will build on these strong foundations as we progress our journey of innovation-led growth and I look forward to continuing to work closely with them in the years to come."

 

The Company confirms that there are no details to be disclosed under Listing Rule 9.6.13R, paragraphs (1) to (6) in respect of the appointment of Craig Boundy as an Executive Director of the Company from the conclusion of the Company's AGM in July 2022.

 

Contact:

Experian

Nadia Ridout-Jamieson Investor queries +44 (0)20 3042 4278

Gerry Tschopp Media queries

 

Tulchan

Graeme Wilson, Louise Male and Guy Bates +44 (0)20 7353 4200

 

About Experian

Experian is the world's leading global information services company. During life's big moments - from buying a home or a car, to sending a child to college, to growing a business by connecting with new customers - we empower consumers and our clients to manage their data with confidence. We help individuals to take financial control and access financial services, businesses to make smarter decisions and thrive, lenders to lend more responsibly, and organisations to prevent identity fraud and crime.

 

We have 20,000 people operating across 44 countries and every day we're investing in new technologies, talented people, and innovation to help all our clients maximise every opportunity. We are listed on the London Stock Exchange (EXPN) and are a constituent of the FTSE 100 Index.

 

Learn more at www.experianplc.com or visit our global content hub at our global news blog for the latest news and insights from the Group.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUWAWRUWUAAAR
Date   Source Headline
16th Oct 20195:13 pmRNSTransaction in Own Shares
15th Oct 20195:13 pmRNSTransaction in Own Shares
14th Oct 20194:48 pmRNSTransaction in Own Shares
11th Oct 20194:55 pmRNSTransaction in Own Shares
7th Oct 201910:58 amRNSShare repurchase programme
4th Oct 20195:05 pmRNSTransaction in Own Shares
3rd Oct 20195:13 pmRNSTransaction in Own Shares
2nd Oct 20195:17 pmRNSTransaction in Own Shares
2nd Oct 20199:15 amRNSAdditional Listing
30th Sep 201912:26 pmRNSTotal Voting Rights
25th Sep 20195:10 pmRNSTransaction in Own Shares
20th Sep 20195:09 pmRNSTransaction in Own Shares
19th Sep 20194:55 pmRNSTransaction in Own Shares
19th Sep 201912:54 pmRNSBlock listing Interim Review
18th Sep 20194:52 pmRNSTransaction in Own Shares
17th Sep 20194:57 pmRNSTransaction in Own Shares
16th Sep 20195:03 pmRNSTransaction in Own Shares
13th Sep 20195:01 pmRNSTransaction in Own Shares
12th Sep 20195:20 pmRNSTransaction in Own Shares
11th Sep 20195:09 pmRNSTransaction in Own Shares
10th Sep 20195:10 pmRNSTransaction in Own Shares
30th Aug 201911:58 amRNSTotal Voting Rights
22nd Aug 20199:37 amRNSAdditional Listing
21st Aug 20198:00 amRNSExperian acquires Look Who's Charging
15th Aug 20195:09 pmRNSTransaction in Own Shares
8th Aug 201911:00 amRNSAcquisition of MyHealthDirect
6th Aug 20195:05 pmRNSTransaction in Own Shares
5th Aug 20195:22 pmRNSTransaction in Own Shares
1st Aug 201912:30 pmRNSDirector/PDMR Shareholding
31st Jul 201911:05 amRNSTotal Voting Rights
25th Jul 20199:30 amRNSAdditional Listing
24th Jul 201912:30 pmRNSResult of AGM
16th Jul 20197:00 amRNSTrading update, First quarter
11th Jul 20195:27 pmRNSTransaction in Own Shares
5th Jul 20195:36 pmRNSSecond Interim Dividend
28th Jun 20193:30 pmRNSShare repurchases
28th Jun 201912:46 pmRNSTotal Voting Rights
21st Jun 20194:05 pmRNSDirector/PDMR Shareholding
21st Jun 20194:00 pmRNSDirector/PDMR Shareholding
14th Jun 20192:35 pmRNSAnnual Financial Report
13th Jun 20193:56 pmRNSDirector/PDMR Shareholding
13th Jun 20199:10 amRNSAdditional Listing
10th Jun 20194:15 pmRNSDirector/PDMR Shareholding
7th Jun 201911:28 amRNSElections for second interim dividend
6th Jun 20194:22 pmRNSTransaction in Own Shares
31st May 201911:19 amRNSTotal Voting Rights
29th May 20197:00 amRNSAppointment of Chairman
15th May 20193:41 pmRNSShare repurchases
15th May 20197:00 amRNSPreliminary results for year ended 31 March 2019
1st May 20199:00 amRNSCompletion of acquisition of Compuscan

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.